Expertise in
35
conditions

Dr. Alina Basnet

Hematology
Upstate Medical University
750 E Adams St, 
Syracuse, NY 
Clinical Trials:Currently Recruiting for 3 Trials
Offers Telehealth
Expertise in
35
conditions
Upstate Medical University
750 E Adams St, 
Syracuse, NY 

Overview

Alina Basnet is a Hematologist in Syracuse, New York. Dr. Basnet is highly rated in 35 conditions, according to our data. Her top areas of expertise are Lung Cancer, Urothelial Cancer, Small Cell Lung Cancer (SCLC), Bone Marrow Aspiration, and Nephrectomy.

Her clinical research consists of co-authoring 75 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology

Licenses

Internal Medicine in IL

Hospital Affiliations

Guthrie Cortland Regional Medical Center
Conemaugh Memorial Medical Center
Our Lady Of Lourdes Memorial Hospital, Inc

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Upstate Medical University
750 E Adams St, Syracuse, NY 13210
Other Locations
The Renzi Cancer Center at Guthrie Cortland Medical Center
34 W Main St, Cortland, NY 13045

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
Enrollment Status: Recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Biological, Drug
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 2
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Enrollment Status: Recruiting
Publish Date: February 04, 2026
Intervention Type: Procedure, Other
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
Enrollment Status: Recruiting
Publish Date: February 04, 2026
Intervention Type: Procedure, Drug, Biological, Other
Study Drugs: Gemcitabine, Cisplatin, Pegfilgrastim
Study Phase: Phase 2
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: a Randomized Phase 3 Non-Inferiority Trial (IMAGINE)
Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: a Randomized Phase 3 Non-Inferiority Trial (IMAGINE)
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2025
Intervention Type: Drug
Study Drugs: Pembrolizumab, Nivolumab, Atezolizumab, Durvalumab, Avelumab
Study Phase: Phase 3
View 3 Less Clinical Trials

75 Total Publications

Search for the Rare Decay D^{0}→μ^{+}μ^{-} in Proton-Proton Collisions at sqrt[s]=13.6  TeV.
Search for the Rare Decay D^{0}→μ^{+}μ^{-} in Proton-Proton Collisions at sqrt[s]=13.6  TeV.
Journal: Physical review letters
Published: June 06, 2025
Similar Doctors
Expertise in
20
conditions
Dr. Stephen Graziano
Hematology
Expertise in
20
conditions
Dr. Stephen Graziano
Hematology

Upstate Medical University

750 E Adams St, 
Syracuse, NY 
 (32.5 miles away)
315-464-8200
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stephen Graziano is a Hematologist in Syracuse, New York. Dr. Graziano is highly rated in 20 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), Bone Marrow Aspiration, and Endoscopy.

Anthony Mato
Expertise in
22
conditions
Dr. Anthony Mato
Hematology
Expertise in
22
conditions
Dr. Anthony Mato
Hematology

Cayuga Medical Center At Ithaca

101 Dates Dr, 
Ithaca, NY 
 (18.5 miles away)
607-272-5414
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Anthony Mato is a Hematologist in Ithaca, New York. Dr. Mato is highly rated in 22 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Expertise in
40
conditions
Dr. Jeffrey Kirshner
Hematology
Expertise in
40
conditions
Dr. Jeffrey Kirshner
Hematology

Office

5008 Brittonfield Pkwy, 
East Syracuse, NY 
 (37.3 miles away)
315-472-7504
Languages Spoken:
English
See accepted insurances

Jeffrey Kirshner is a Hematologist in East Syracuse, New York. Dr. Kirshner is highly rated in 40 conditions, according to our data. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Lung Cancer, and HER-2 Positive Breast Cancer.

Frequently Asked Questions about Dr. Alina Basnet

How do I make an appointment with Dr. Alina Basnet?

You can book an appointment with Dr. Alina Basnet by calling their office at 315-464-8200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Alina Basnet a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Alina Basnet is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Alina Basnet specialize in?

While Dr. Alina Basnet is a Hematology, they have specific expertise in Lung Cancer, Urothelial Cancer, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Alina Basnet participate in research or clinical trials?

Yes. Dr. Alina Basnet has published 75 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Alina Basnet's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Alina Basnet accept my insurance?

Dr. Alina Basnet accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 315-464-8200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Basnet's expertise for a condition
ConditionClose
    View All 30 Advanced Conditions
    View All 53 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile